SCHEMBL3556438

SCHEMBL3556438

COCc1ccccc1-c1ccc(C(=O)N2Cc3ccc(C(=O)NCc4cccnc4)n3Cc3ccccc32)cc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
GAA P10253 2/20 0.39
NAMPT P43490 1/20 0.39
AVPR2 P30518 1/20 0.38
LMNA P02545 2/20 0.38
RECQL P46063 1/20 0.38
USP2 O75604 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PKM P14618 1/20 0.38
ROCK2 O75116 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
DRD2 P14416 2/20 0.37
DRD3 P35462 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
BLM P54132 1/20 0.37
VNN1 O95497 1/20 0.37
ROCK1 Q13464 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3554172 0.92 NAMPT (0.42) ALDH1A1GAANAMPTAVPR2LMNA
SCHEMBL3558808 0.90 AVPR2 (0.45) ALDH1A1GAANAMPTAVPR2RECQL
SCHEMBL3554197 0.90 AVPR1A (0.41) ALDH1A1GAANAMPTAVPR2LMNA
SCHEMBL3555113 0.89 NAMPT (0.40) ALDH1A1GAANAMPTAVPR2LMNA
SCHEMBL3554157 0.89 DGAT2 (0.44) ALDH1A1NAMPTAVPR2LMNANPSR1
SCHEMBL3550256 0.89 USP2 (0.45) ALDH1A1NAMPTAVPR2LMNAUSP2
SCHEMBL3553328 0.88 AVPR2 (0.40) NAMPTAVPR2LMNAUSP2PKM
SCHEMBL3553530 0.88 HTT (0.43) ALDH1A1NAMPTAVPR2LMNAROCK2
SCHEMBL3552860 0.88 LMNA (0.42) ALDH1A1GAANAMPTAVPR2LMNA
SCHEMBL3558987 0.88 ALDH1A1 (0.46) ALDH1A1GAANAMPTAVPR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678787-B2 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists WYETH (US) 2010-03-16 US claimed
US-20060287522-A1 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists WYETH (US) 2006-12-21 US claimed
US-7678787-B2 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists WYETH (US) 2010-03-16 US disclosed
US-20060287522-A1 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists WYETH (US) 2006-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060287522-A1 Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists FSHR, GNRHR, PRLHR ALDH1A1 4219/4885GAA 4783/4885NAMPT 1960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.